These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25529873)

  • 21. Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
    Vogl TJ; Stupavsky A; Pegios W; Hammerstingl R; Mack M; Diebold T; Lodemann KP; Neuhaus P; Felix R
    Radiology; 1997 Dec; 205(3):721-8. PubMed ID: 9393527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.
    Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R
    J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.
    Hwang HS; Kim SH; Jeon TY; Choi D; Lee WJ; Lim HK
    Korean J Radiol; 2009; 10(3):294-302. PubMed ID: 19412518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of gadobenate dimeglumine on MRI of mouse liver metastasis model constructed by orthotopic transplantation of highly metastatic murine colon carcinoma (C38-OT7): comparison with gadopentetate dimeglumine].
    Yoshikawa K; Takamura T; Funahashi Y; Senba T; Ogawa T; Ono H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):380-5. PubMed ID: 10459282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadobenate dimeglumine-enhanced liver MRI as the sole preoperative imaging technique: a prospective study of living liver donors.
    An SK; Lee JM; Suh KS; Lee NJ; Kim SH; Kim YJ; Han JK; Choi BI
    AJR Am J Roentgenol; 2006 Nov; 187(5):1223-33. PubMed ID: 17056909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
    Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
    Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers.
    Vogl TJ; Pegios W; McMahon C; Balzer J; Waitzinger J; Pirovano G; Lissner J
    AJR Am J Roentgenol; 1992 Apr; 158(4):887-92. PubMed ID: 1546612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.
    Morana G; Grazioli L; Kirchin MA; Bondioni MP; Faccioli N; Guarise A; Schneider G
    Invest Radiol; 2011 Apr; 46(4):225-39. PubMed ID: 21102346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent.
    Choi JY; Choi JS; Kim MJ; Lim JS; Park MS; Kim JH; Chung YE
    J Magn Reson Imaging; 2010 Mar; 31(3):571-8. PubMed ID: 20187199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.
    Petersein J; Spinazzi A; Giovagnoni A; Soyer P; Terrier F; Lencioni R; Bartolozzi C; Grazioli L; Chiesa A; Manfredi R; Marano P; Van Persijn Van Meerten EL; Bloem JL; Petre C; Marchal G; Greco A; McNamara MT; Heuck A; Reiser M; Laniado M; Claussen C; Daldrup HE; Rummeny E; Kirchin MA; Pirovano G; Hamm B
    Radiology; 2000 Jun; 215(3):727-36. PubMed ID: 10831691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of increasing the flip angle during the hepatocyte phase of gadobenate dimeglumine-enhanced 1.5T MRI in cirrhotic patients with hepatocellular carcinoma.
    Lee EJ; Kim DJ; Cho ES; Kim KA
    J Magn Reson Imaging; 2016 Mar; 43(3):713-9. PubMed ID: 26290384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    Kirchner J; Sawicki LM; Deuschl C; Grüneisen J; Beiderwellen K; Lauenstein TC; Herrmann K; Forsting M; Heusch P; Umutlu L
    PLoS One; 2017; 12(7):e0180349. PubMed ID: 28683109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.